Pharma Marketing Network

MARCH 26, 2025

Opportunities Driving Adoption AI presents clear benefits for pharma marketers: 1. Misuse or insufficient anonymization can trigger HIPAA or GDPR violations. HIPAA, GDPR) are followed and no discriminatory practices occur. This lack of explainability creates issues in proving compliance with promotional review standards.

HIPAA 64

HIPAA Medical Compliance Documentation 64

Pharma Marketing Network

JANUARY 11, 2025

FDA Guidelines for DTC Ads: The FDA requires ads to present both benefits and risks equally. Focus on Data Privacy: With increasing scrutiny on data collection practices, adhering to GDPR and HIPAA standards is essential to maintain trust. Missteps can lead to hefty fines and reputational damage.

HIPAA 52

HIPAA 52

Pharma Marketing Network

MARCH 20, 2025

Additionally, privacy regulations such as GDPR and HIPAA are impacting data-driven advertising. Despite these challenges, regulatory changes also present opportunities. Healthcare brands must prioritize ethical data usage and consent-based marketing, requiring additional investment in privacy-compliant technologies.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies HIPAA Biosimilars 59

Pharma Marketing Network

MARCH 5, 2025

With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. Being present at the top of search results improves brand awareness. However, the landscape isnt simple.

HIPAA 52

HIPAA Diabetes Hospitals 52

pharmaphorum

NOVEMBER 15, 2022

At present, the most-used health apps are those for fitness (46%), patient portal apps (43%), and mental health apps (29%). This facilitates patient self-empowerment in the form of micro-behavioural changes and/or adjustments. The post Data privacy concerns don’t hinder digital health app usage appeared first on.

HIPAA 130

HIPAA Medical Records 130

Drug Channels

JULY 11, 2022

Harness data-driven tech offerings to combat the urgent public health crisis and provide patients and stakeholders with unrivaled support services in an all-encompassing state-of-the-art hub.

Specialty Pharmacies 98

Specialty Pharmacies HIPAA Biosimilars 98

Pharma Marketing Network

OCTOBER 6, 2021

Reaching these audiences is further complicated by HIPAA and FTC regulations — not to mention international laws like GDPR and the gradual deprecation of third-party cookies, which all marketers must consider. Even brilliant creative is unlikely to attract attention when presented in a low-quality placement.

HIPAA 98

HIPAA Pharmaceutical Companies Pharmaceutical Companies 98

National Association of Boards of Pharmacy

JULY 31, 2024

HIPAA Notice of Privacy Practices: If you are considered a “covered entity” under federal law, your HIPAA Notice must be prominently placed on your customer-facing website. For US-based pharmacies, Healthcare Merchant Accreditation is also the first step in obtaining the Digital Pharmacy Accreditation.

HIPAA 45

HIPAA Documentation Compounding 45

Pharma Marketing Network

JUNE 11, 2025

eDetailing platforms allow for interactive presentations, data capture, and follow-up scheduling, all from a compliant digital environment. In a landscape increasingly governed by data privacy regulations like HIPAA and GDPR, companies that practice transparent, secure data handling will build greater trust with their audiences.

Communication 89

Communication HIPAA 89

Pharma Marketing Network

FEBRUARY 19, 2025

Challenges in Pharma Email Marketing Pharma brands face unique barriers that other industries dont , such as: Strict compliance regulations (FDA, GDPR, HIPAA) that limit messaging. FDA and Fair Balance Messaging All promotional emails must include fair balance messaging benefits and risks must be presented equally.

HIPAA 72

HIPAA Diabetes Labelling Communication 72

Viseven

JUNE 4, 2025

Ensure HIPAA compliance : Protect patient data by using secure and compliant communication channels. Providers should partner with platforms capable of signing Business Associate Agreements (BAAs) to guarantee HIPAA compliance. But this challenge presents a great opportunity.

Communication 52

Communication Health and Personal Care Stores HIPAA Medical Records 52

Eye on FDA

NOVEMBER 17, 2020

Because the regulatory oversight of COVID became highly politicized, and after some missteps by FDA, some states have indicated that any federal decision will be reviewed, but that does not seem likely to present much a barrier in terms of timeline, if at all. In addition, the process of vaccination takes time.

Communication 81

Communication Vaccines HIPAA Documentation 81

Pharma Marketing Network

NOVEMBER 1, 2024

The challenge is not just collecting data, but doing so ethically and in compliance with laws like GDPR in Europe and HIPAA in the United States. Personalized Marketing at Scale Patients now expect personalized experiences, which presents both an opportunity and a challenge. Why is compliance challenging in digital marketing?

HIPAA 52

HIPAA Communication 52

Pharma Marketing Network

MARCH 3, 2025

Challenges in Pharma CRO: Regulatory restrictions limit the way pharma brands present information. CRO best practices for patient engagement include: Clearly stating HIPAA compliance and data privacy policies. Use transparent data collection methods, privacy-centric CTAs, and ensure all content aligns with FDA and HIPAA guidelines.

HIPAA 52

HIPAA Dosage Diabetes 52

Pharmaceutical Technology

AUGUST 31, 2022

However, this presents challenges for healthcare companies. Regulations such as the EU’s GDPR, the US’s HIPAA, and California’s CCPA are in place to give people more control over what personal data a company can collect, store and share. Managing data and consent for wearables.

HIPAA 52

HIPAA Communication Hospitals 52

Pharma Marketing Network

JANUARY 7, 2025

Navigating HIPAA regulations while tailoring messages requires careful planning and ethical decision-making. Additionally, the rise of social media marketing presents a new regulatory gray area. This fosters trust, enhances patient engagement, and ultimately builds brand loyalty.

HIPAA 52

HIPAA Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 1, 2022

A digital twin of the human body presents immense potential for the future of diagnostics. At this year’s American Diabetes Association annual scientific session, clinical trial data was presented that analysed 199 diabetes patients for an average of four years. At the start of the study, patients had an average A1C level of 9%.

Health and Personal Care Stores 52

Health and Personal Care Stores Diabetes HIPAA Communication 52

pharmaphorum

DECEMBER 13, 2022

Historically, equivalency presented a primary hurdle in the adoption of eCOA BYOD for clinical trials. Therefore, vendor applications must adhere to HIPAA and GDPR data protection regulations, including encryption and multifactor authentication.

Data Entry 59

Data Entry HIPAA Communication 59

Board Vitals - Pharmacist

JANUARY 18, 2023

Each digital “case” presents a patient history and a series of questions and exercises designed to test the subscriber’s diagnostic and therapeutic skills. While social media supports patient education, research dissemination and educational discussions, it can also increase the risk for HIPAA breaches or unprofessional conduct.

Medical Schools 52

Medical Schools HIPAA Communication 52

Pharmaceutical Technology

OCTOBER 25, 2022

The multiple platforms and apps used in professional and personal lives present significant challenges for data management systems. Breaches of HIPAA in the US can result in fines of up to $50,000. Otherwise, theoretically, they could be in breach of regulations.”. Grouping and matching for medical data.

HIPAA 52

HIPAA Pharmaceutical Companies Pharmaceutical Companies Medical Records 52

Putting Patients First Blog

MARCH 13, 2023

The NHC encourages CMS to address barriers to access that prior authorization and other utilization management practices present for patients who need access to necessary prescription drugs. We also note this rule specifically does not apply to prescription drugs.

HIPAA 40

HIPAA Hospitals Documentation Communication 40

pharmaphorum

JUNE 11, 2021

However, data-intensive, decentralised clinical trials also present a major risk to healthcare participants through cybercrime and data privacy vulnerability. HIPAA in the United States, a regulatory reference, was designed to protect patient privacy but not necessarily data security.

Vaccines 111

Vaccines HIPAA Immunity Immunization 111

Board Vitals - Pharmacist

JUNE 14, 2018

The NCLEX-RN® exam tests more than your knowledge of content – it tests your ability to use that knowledge, and apply critical thinking skills when presented with a clinical scenario. They also have a free drug reference with a lot of good, clearly presented information. Just do a search for your topic.

HIPAA 52

HIPAA Vaccines 52

pharmaphorum

OCTOBER 4, 2022

This was delivered through a patient-centric video about the Biobank study presented to the patient on an iPad, Lee explained. Once the video is presented, the patient is asked to take a knowledge check to ensure that they have fully understood the consent process.

Documentation 105

Documentation Data Entry HIPAA 105

FDA Law Blog: Biosimilars

MAY 26, 2025

While ensuring that a pre-enforcement challenge is properly presented to a court is not a simple task, it can be done, and for those interested, there may be much to challenge. Nevertheless, individuals and organizations could be in receipt of grand jury or HIPAA subpoenas requesting records, or they could be visited by federal agents.

Labelling 59

Labelling HIPAA Documentation Pharmaceutical Companies 59